MD517G2 - Metodă de tratare a febrei tifoide - Google Patents

Metodă de tratare a febrei tifoide

Info

Publication number
MD517G2
MD517G2 MD96-0034A MD960034A MD517G2 MD 517 G2 MD517 G2 MD 517G2 MD 960034 A MD960034 A MD 960034A MD 517 G2 MD517 G2 MD 517G2
Authority
MD
Moldova
Prior art keywords
proteins
treatment
correction coefficient
optimal
body mass
Prior art date
Application number
MD96-0034A
Other languages
English (en)
Russian (ru)
Other versions
MD517F1 (ro
Inventor
Victor Cojocari
Original Assignee
Cojocaru Victor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of MD517F1 publication Critical patent/MD517F1/ro
Publication of MD517G2 publication Critical patent/MD517G2/ro
Application filed by Cojocaru Victor filed Critical Cojocaru Victor
Priority to MD96-0034A priority Critical patent/MD517G2/ro

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Invenţia se referă la terapie şi poate fi folosită în tratamentul pacienţilor cu deficit nutriţional în condiţii extreme.Metoda constă în faptul că tratamentul medicamentos se efectuează în paralel cu alimentaţia enterală cu hidrolizate de albumină, doza căreia va fi calculată folosind formula:Bopt.=2,07×Mopt.+2,07×Mopt.×(Kc+Ks+Kt) - (Bh-Bh×Ku), în care:Bopt. este cantitatea optimă de albumină, necesară bolnavilor cu febră tifoidă şi deficit nutriţional (g);2,07 este necesitatea optimă în albumină la 1 kg de masă corporală timp de 24 de ore la persoanele cu activitate fizică înaltă până la spitalizare (g);Mopt. este masa corporală optimă a omului (kg);Kc este coeficientul de corecţie conform factorilor climaterici;Ks este coeficientul de corecţie conform factorilor de stres;Kt este coeficientul de corecţie conform temperaturii corporale;Bh este cantitatea de albumină în dieta spitalicească (g);Ku este coeficientul de corecţie conform gradului de utilizare a albuminei.Metoda propusă de tratare permite obţinerea următorului rezultat tehnic: micşorarea duratei tratamentului, frecvenţei complicaţiilor şi recidivelor la bolnavii trataţi în condiţii extreme.
MD96-0034A 1996-12-08 1996-12-08 Metodă de tratare a febrei tifoide MD517G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD96-0034A MD517G2 (ro) 1996-12-08 1996-12-08 Metodă de tratare a febrei tifoide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD96-0034A MD517G2 (ro) 1996-12-08 1996-12-08 Metodă de tratare a febrei tifoide

Publications (2)

Publication Number Publication Date
MD517F1 MD517F1 (ro) 1996-04-30
MD517G2 true MD517G2 (ro) 1996-11-30

Family

ID=19738793

Family Applications (1)

Application Number Title Priority Date Filing Date
MD96-0034A MD517G2 (ro) 1996-12-08 1996-12-08 Metodă de tratare a febrei tifoide

Country Status (1)

Country Link
MD (1) MD517G2 (ro)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Васильев П.С. и др. Сочетанное применение препаратов парентерального белкового питания, энергетических компонентов и стимуляторов биосинтеза белка. Методические рекомендации. М., 1982, р. 30. *
Ляшенко Ю.И., Иванов А.И. Смешанные инфекции, Медицина, М. 1980, р. 81-85. *

Also Published As

Publication number Publication date
MD517F1 (ro) 1996-04-30

Similar Documents

Publication Publication Date Title
HUT70216A (en) Methods and pharmaceutical compositions for the treatment of diseases with interferon while reducing side effects
GR900100659A (en) Dosage form for administering oral hupoglycemic glipizide
ES2010561A6 (es) Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina.
Bao et al. Twenty-item behavioral neurological assessment for normal newborns in 12 cities of China
NO172043C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater
MY105798A (en) Treatment of leukocyte dysfunction with gm-csf.
MD517G2 (ro) Metodă de tratare a febrei tifoide
TW200517119A (en) Method of treatment using interferon-tau
EP0228239A3 (en) Preparation of a medicament for arthritis and rheumatism
CN1052403C (zh) 活性离子钙制作方法
CROSS Benign parotid tumors
CN1057001C (zh) 一种治疗类风湿的纯中药胶囊
UA31141A (uk) Спосіб лікування алергічних станів
MD885G2 (ro) Metodă de tratament al colitei, hepatitei, pielonefritei, maladiilor alergice ale tegumentelor şi căilor respiratorii
CN2215320Y (zh) 婴幼儿支气管炎哮喘专治药物背心
CN1122702A (zh) 气管炎、哮喘、肺肿安药物
Ycng-bo et al. Cyclophosphamide impulsion therapy for child patients with systemic lupus erythematosus (a report of 6 cases)
张红星 32 cases of tennis elbow treated by the three-needle therapy on the elbow
Weiya et al. Evaluation of Effects of Five Orthodontic Adhesives in Clinical Applications and Related Nursing Operations
曹文钟 et al. Dr. Gao Lishan's experience in treating pain syndromes by acupuncture
CN1065403A (zh) 痛经安
엄인웅 comprehensive treatment incase of bilateral internal derangement of temporomandibular joint
RICO et al. Harry H., aged eighteen months, was at birth unusually plump and vigorous, and for twelve months thereafter his
de W Practical Points in the Home Treatment of Tuberculosis.
Hori Antibiotic medication for patients with tongue pain

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20161208